全文获取类型
| 收费全文 | 410篇 |
| 免费 | 272篇 |
| 国内免费 | 13篇 |
专业分类
| 妇产科学 | 22篇 |
| 基础医学 | 16篇 |
| 临床医学 | 29篇 |
| 内科学 | 18篇 |
| 皮肤病学 | 2篇 |
| 神经病学 | 3篇 |
| 特种医学 | 4篇 |
| 外科学 | 6篇 |
| 综合类 | 122篇 |
| 预防医学 | 6篇 |
| 眼科学 | 3篇 |
| 药学 | 80篇 |
| 1篇 | |
| 中国医学 | 373篇 |
| 肿瘤学 | 10篇 |
出版年
| 2024年 | 8篇 |
| 2023年 | 39篇 |
| 2022年 | 53篇 |
| 2021年 | 70篇 |
| 2020年 | 84篇 |
| 2019年 | 97篇 |
| 2018年 | 85篇 |
| 2017年 | 60篇 |
| 2016年 | 18篇 |
| 2015年 | 17篇 |
| 2014年 | 39篇 |
| 2013年 | 25篇 |
| 2012年 | 32篇 |
| 2011年 | 30篇 |
| 2010年 | 10篇 |
| 2009年 | 10篇 |
| 2008年 | 8篇 |
| 2007年 | 6篇 |
| 2006年 | 1篇 |
| 2005年 | 1篇 |
| 2004年 | 1篇 |
| 2003年 | 1篇 |
排序方式： 共有695条查询结果，搜索用时 156 毫秒
81.
类风湿关节炎可发生于任何年龄,女性多见,早期以关节滑膜炎为主要临床表现。关节滑膜的慢性炎症使大量炎性细胞浸润,侵犯软骨及骨组织,形成侵袭性血管翳,破坏关节软骨,从而导致关节结构破坏、功能受损。针刀治疗类风湿关节炎主要表现在松解粘连结缔组织、解除局部高压状态、建立关节力学平衡等方面,其疗效机制有改善形态学病变、改善局部血液循环、抑制自由基、调节细胞因子。针刀疗法在治疗类风湿关节炎方面疗效确切,值得临床推广应用。 相似文献
82.
针灸治疗原发性高血压目前已经在临床上得到认可。本文对原发性高血压的发病机制和针刺治疗取穴及方法进行概述,旨在为针灸治疗原发性高血压的研究提供参考。 相似文献
83.
从肺脾论治小儿太息症是对中医理论的完善,文章从对太息症的中西医认识、小儿太息症气机不畅与肺脾的关系等方面进行阐述,为临床维护小儿身心健康提供了新思路。 相似文献
84.
Wang Xianliang Hou Yazhu Mao Jingyuan Zhao Yingqiang Niu Tianfu Yuan Ruyu Wang Yonggang Cui Jinrong Shi Le Jia Xiuli Fan Ruihong Lin Qian Zhang Yan Li Zhijun Shang Hongcai Wang Baohe Wang Hongwu Wang Henghe Zhang Boli 《中医杂志(英文版)》2017,37(6):756-766
Objective
To assess the efficacy and safety in patients with chronic heart failure (CHF) of Western medication plus Traditional Chinese Medicine (TCM) preparations.Methods
This prospective, single-blind, randomized, controlled, and multicenter clinical trial began on September 17, 2008, and was completed on June 25, 2011. A total of 340 inpatients, aged 40–79 years, with exacerbating CHF from 10 hospitals were enrolled and randomly allocated within 24 h of admission. The trial included three intervention periods. During hospitalization, the control group received western medication for CHF and the treatment group received Danhong injection with Shenfu injection or Shenmai injection. After discharge, all patients were treated with Qiliqiangxin capsules and Buyiqiangxin tablets or a placebo for 6 months. After the 6-month intervention, both groups received only continuous western medication. The primary endpoint was all-cause mortality. The efficacy assessments were as follows: B-type natriuretic peptide (BNP), Lee's HF score, the 6-minute walking test (6MWT), left ventricular ejection fraction (LVEF), and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The safety assessments were as follows: blood and urine routine examination, hepatic and renal function, electrolytes in blood and adverse events.Results
Compared with the control group, the treatment group showed a 30.99% reduction in all-cause mortality and an improved survival rate. The treatment group showed greater improvement in 6MWT (P = 0.02) than the control group on discharge, after 12-month follow-up, there was a time-group interaction for MLHFQ (P = 0.03). Incidence rate of adverse events and other relevant safety indexes were not statistically significant between the two groups.Conclusion
Western medication plus TCM treatment can increase 6-minute walking distance (improve exercise tolerance) and quality of life with heart failure patients. 相似文献85.
Li Huanan Wang Jingui Zhang Wei Zhao Na Hai Xinhua Sun Shiquan Sun Qing Han Yihao Zhang Runchen Ma Fei 《中医杂志(英文版)》2017,37(6):819-826
Objective
To evaluate the effect of the traditional Chinese procedure abdominal Tuina (AT) on chronic fatigue syndrome (CFS).Methods
This randomized, single assessor-blinded clinical trial was carried out from May 2014 to April 2015. Eighty participants in the trial were divided randomly into two groups: experimental group and control. The experimental group (40 cases) was treated by AT and the control group (40 cases) by acupuncture. Each treatment was conducted once a day, 5 d for one course, at an interval of 2 d between each course. The whole treatment course lasted for 4 weeks. To ascertain the effect of AT and acupuncture, Fatigue Scale-14 (FS-14), Self-rating Anxiety Scale (SAS) and Hamilton Rating Scale for Depression (HAMD) scores were used before and after treatment. Patients were followed up for 3 months after treatment.Results
After treatment for 4 weeks, 77 patients (39 cases in the experimental group and 38 cases in the control group) completed the trial. The FS-14, SAS and HAMD scores decreased (P < 0.05) significantly compared with those before treatment in both groups. The FS-14 and HAMD (P < 0.05) scores in the experimental group were much lower than those in the control group. The difference in SAS scores between the two groups was not significant. In the final follow-up, CFS in two cases in the experimental group and three in the control group recurred, but the difference was not significant. The scores for the FS-14, SAS and HAMD in the experimental group were superior to those of the control group, and the difference was significant (P < 0.05). No serious adverse events and few adverse events were observed.Conclusion
AT elicited a more efficacious effect than acupuncture alone on CFS. 相似文献86.
Shi Lijie Shi Lei Liu Leilei Feng Xiuxian Wang Jing Yang Qiang Chai Shiwei Gou Jing Zang Fenglin He Sufei 《中医杂志(英文版)》2017,37(4):452-460
Objective
To evaluate the effect of decoction prepared with Yang-activating and stasis-eliminating medicinals from Traditional Chinese Medicine (TCM) on the intestinal mucosal permeability in rats with ulcerative colitis induced by dextran sulfate sodium (DSS).Methods
Totally 55 male Wistar rats (body weight of 170–190 g) were randomly divided into the blank group (n = 10) and the model duplication group (n = 45). The blank group was not intervened, while the other was modeled with 5% dextran sulfate sodium by gavaging in a dosage of 4 mL per day to induce ulcerative colitis, a total of 7 days. Then, the model rats were divided into model blank group, mesalazine group and TCM group, and each group was consisted of 15 rats. They were given retention enema 10 min with normal saline, mesalazine enema (0.036 g/mL), and Yang-activating and stasis-eliminating decoction [0.54 g/mL of a decoction boiled by Puhuang (Pollen Typhae), Xiebai (Bulbus Allii Macrostemonis) and Wulingzhi (Faeces Trogopteri)] for 10 days respectively. Afterwards, all of the rats were evaluated by disease activity index (DAI), histological changes of distal colon, expression of occludin protein and ultrastructure of intestinal epithelial cells. Furthermore, ratio of lactulose to mannitol (L/M) discharged in urine was evaluated.Results
Comparing the results between TCM and model control groups, scores of DAI and histological lesions decreased significantly (P = 0.000 < 0.01), ultrastructures of intestinal epithelial cells and tight junctions were more complete. The expression of occludin protein (P = 0.001 < 0.01) increased while the L/M value decreased significantly (P = 0.000 < 0.01) in TCM group. There was no statistical difference between the TCM and mesalazine groups in results of each item (P > 0.05).Conclusion
The decoction prepared with Yang-activating and stasis-eliminating TCM medicianls can restore intestinal mucosal epithelial cells and tight junctions the model rats with ulcerative colitis; it can reduce histological lesions and protect the permeability of intestinal mucosa barrier in the rats as well. 相似文献87.
Gao Hui Xia Tian Ma Ruihong Zhao Zhimei Song Xueru Wang Baojuan Liu Lijing Han Kaimei Wang Guoqing Fu Yu Hao Guimin 《中医杂志(英文版)》2017,37(4):530-537
Objective
To evaluate the clinical efficacy and safety of Heyan Kuntai capsule (HYKT) in treating women with infertility caused by diminished ovarian reserve (DOR).Methods
One hundred eight eligible patients from three Chinese hospitals were randomly divided into an HYKT treatment group (n = 55) ora dehydroepiandrosterone (DHEA) treatment group (n = 53). Patients in the HYKT group were treated orally with four 0.5 g HYKT three times a day; patients in the DHEA group were treated with one 25.0 mg DHEA capsule three times a day. All patients were treated for 3 months and followed up over a 3-month period.Results
Of 108 patients, 12 dropped out: six from the HYKT group, and six from the DHEA group. Eleven patients got pregnant during the treatment. Serum anti-Müllerian hormone levels and antral follicle counts increased significantly in both groups after treatment (P < 0.05) especially in the HYKT group (P < 0.05). Serum follicle stimulating hormone (FSH) levels and FSH/luteinizing hormone ratios decreased (P < 0.05) with no significant difference between the two groups. Estradiol levels in the HYKT group and DHEA-sulfate levels in the DHEA group both increased (P < 0.05). The spontaneous pregnancy rates were 12% and 11% in the HYKT and DHEA groups, respectively (not significant). During the follow-up period, 16 patients in the HYKT group underwent in vitro fertilization-embryo transfer (IVF-ET) and the number of retrieved oocytes was (5.1 ± 1.8). In DHEA group, 20 patients underwent IVF-ET and the number of retrieved oocyte was (4.2 ± 1.9) (not significant); clinical pregnancy rates were 38% in the HYKT group and 20% in DHEA group (not significant). No significant adverse reactions were observed.Conclusion
HYKT can improve the ovarian reserve and hormone levels in patients with infertility caused by DOR. Pregnancy rates after HYKT treatment were similar to those of DHEA treatment. HYKT might be an alternative to the treatment of infertility caused by DOR. 相似文献88.
目的:探讨独活续断汤治疗不同证型腰间盘突出症的临床疗效,对生活能力,血清疼痛因子,骨形成蛋白-7(BMP-7),聚集蛋白聚糖(Aggrecan)的影响。方法:将2017年1月至2018年6月天津中医药大学第一附属医院收治的非急症期腰间盘突出症患者121例随机分为观察组(62例)和对照组(59例),两组患者均给予复位手法治疗后绝对卧床休息,观察组给予独活续断汤治疗,150 mL/次,3次/d口服,对照组给予布洛芬300 mg/次、维生素B110 mg/次,2次/d口服,每周服药5 d,停药2 d,两组患者均连续治疗4周,观察两组患者治疗前后视觉模拟评分(VAS),改良Oswestry功能障碍指数变化;酶联免疫吸附测定(ELISA)检测治疗前后血清P物质(SP),多巴胺(DA),五羟色胺(5-HT),BMP-7及Aggrecan含量变化。结果:与本组治疗前比较,两组患者VAS,改良Oswestry功能障碍指数评分均降低(P0.01),血清BMP-7,Aggrecan含量升高,SP,DA,5-HT含量降低(P0.01);与对照组治疗后比较,观察组患者VAS,改良Oswestry功能障碍指数评分均降低(P0.01),临床疗效提高(P0.01),血清BMP-7,Aggrecan含量更高,SP,DA及5-HT含量更低(P0.01);在所有证型中肝肾阴虚型患者疗效最佳。结论:独活续断汤对不同类型腰间盘突出症均有一定疗效,但对于肝肾阴虚型患者疗效最佳。 相似文献
89.
目的应用数据挖掘技术,研究当代中医治疗慢性肾炎蛋白尿的证治方药规律。方法检索并筛选中国知网、万方医学网数据库中近20年间发表的有关当代中医治疗慢性肾炎蛋白尿的文献,提取其中的证治方药信息,建立数据库。在统计软件中运用频数统计、关联规则分析、聚类分析等方法进行数据挖掘,探求相关证治方药规律。结果①中医证型由高频至低频依次为脾肾两虚证、气阴两虚证、风邪外袭证、肝肾阴虚证、湿热壅盛证等。②按照方剂功用进行分类汇总,其中补益剂出现频率最高,为252次;其次为祛湿剂,为128次;再次为逐瘀剂,为51次。③按照方剂应用频次进行统计,排名前5位的方剂为参苓白术散(30次)、六味地黄丸(29次)、参芪地黄汤(20次)、二至丸(18次)、金匮肾气丸(18次)。④应用频次最多的中药为黄芪。⑤经中药数据聚类分析后,发现"茯苓、地黄、山茱萸、山药、泽泻、牡丹皮、黄芪、白术""党参、菟丝子、陈皮、甘草、金樱子、芡实""丹参、益母草、当归、川芎、赤芍、桃仁、红花"等5个新的药物组合。⑥慢性肾炎蛋白尿的核心中药主要为补气健脾药(黄芪、白术、茯苓),以及补肾涩精药(山茱萸、山药、地黄、芡实)。结论①当代中医认为,慢性肾炎蛋白尿的基本病机在于脾肾两虚,风邪、湿热、瘀血是其常见病理因素,临床上可以从脾肾两虚、气阴两虚、肝肾阴虚、风邪外袭、湿热壅盛、血瘀六个证型进行辨证论治。②参苓白术散、六味地黄丸及参芪地黄汤是临床使用率较高的方剂;治疗慢性肾炎蛋白尿的核心中药主要为补气健脾药(黄芪、白术、茯苓),以及补肾涩精药(山茱萸、山药、地黄、芡实)。 相似文献
90.
[目的]研究中药复方熄风胶囊对氯化锂-匹罗卡品致痫大鼠海马电压门控性Ⅰ型钠通道α亚基蛋白(Nav1.1)表达的影响。[方法]建立氯化锂-匹罗卡品致痫大鼠模型。实验大鼠随机分为5组:空白组、模型组、熄风胶囊低剂量治疗组(熄低组)、熄风胶囊中剂量治疗组(熄中组)、熄风胶囊高剂量治疗组(熄高组)。分别通过免疫组织化学染色法检测实验大鼠海马Nav1.1的表达。[结果] Nav1.1蛋白在IE大鼠海马的表达,发现致痫大鼠海马CA1区和DG区神经元结构基本正常,且Nav1.1变化不明显,在CA3区,模型组致痫大鼠神经元变性、坏死明显,Nav1.1在神经元变性、坏死部位染色变浅,甚至消失,在变性、坏死神经元周围的正常组织中染色增强。其中,模型组可见CA3区神经元退变、坏死,Nav1.1在神经元退变、坏死部位染色变浅,甚至消失,而在熄风胶囊治疗组中,随剂量增大,退变、消失的神经元减少,同时棕褐色区域减少程度减低,均与剂量成正相关,但在变性、坏死的神经元周围的正常组织中染色增强不明显,而且从定量分析来看,模型组Nav1.1的表达量增多,而各熄风胶囊治疗组却增加不明显。[结论]熄风胶囊可能通过保护海马神经元,调节IE大鼠海马神经元Nav1.1的表达,推测其可通过对钠通道的抑制作用以降低神经元细胞膜兴奋性而发挥抗癫痫作用。 相似文献